Abstract

BioID was performed using FlagBirA⁎ (the R118G biotin ligase mutant protein) and FlagBirA⁎-Myc in HEK293 T-REx cells maintained both under standard cell culture conditions and as mouse xenografts. The mass spectrometry dataset acquired in this study has been uploaded to the MassIVE repository with ID: MSV000078518, and consists of 28 ⁎.raw MS files acquired on an Orbitrap Velos instrument, collected in data-dependent mode. iProphet processed MS/MS search results are also included as a reference. This study has been published as “BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors”, by Dingar et al. in the Journal of Proteomics, 2014 [1].

Highlights

  • Princess Margaret Cancer Centre, University Health Network, and Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada article info

  • The mass spectrometry dataset acquired in this study has been uploaded to the MassIVE repository with ID: MSV000078518, and consists of 28 n.raw MS files acquired on an Orbitrap Velos instrument, collected in data-dependent mode. iProphet processed MS/MS search results are included as a reference

  • Biology Proteomics, Protein–protein interactions Mass spectrometry RAW files Mass Spectrometry (Thermo Orbitrap Velos) RAW unprocessed files Bait protein maintained under standard culture conditions and as xenografts BioID using the human c-MYC protein as bait MassIVE Available on MassIVE, ID: MSV000078518

Read more

Summary

Data Article

BioID data of c-MYC interacting protein partners in cultured cells and xenograft tumors. BioID was performed using FlagBirAn (the R118G biotin ligase mutant protein) and FlagBirAn-Myc in HEK293 T-REx cells maintained both under standard cell culture conditions and as mouse xenografts. This study has been published as “BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors”, by Dingar et al in the Journal of Proteomics, 2014 [1].

Specifications Table
Value of the data
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.